For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : GlucoRx Aidex (real-time continuous glucose monitoring) - Type II Diabetes (Children and Young People)
PAD Profile : GlucoRx Aidex (real-time continuous glucose monitoring) - Type II Diabetes (Children and Young People)
Traffic Light Status
Status 1 of 1.
- Device
Guidelines
No guidelines returned.
Other Drugs
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
Other Indications
- Type II Diabetes (Children and Young People)
- Congenital hyperinsulinism
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type I Diabetes
- Type I Diabetes
- Type II Diabetes (Children and Young People)
Additional Documents
No additional documents returned.
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed that real time Continuous Glucose Monitoring (rtCGM) or intermittently scanned Continuous Glucose Monitoring (isCGM) is offered to children and young people with type II diabetes in line NG18 Diabetes (type 1 and type 2) in children and young people: diagnosis and management).
However a NON-FORMULARY traffic light status has been agreed for the following device.
GlucoRx Aidex:
- Is not licensed for insulin dosing (non-adjunctive use)
- Requires the user to verify their sensor glucose level with a capillary blood glucose test before insulin bolus for a meal. This adds to the diabetes burden for the patient and increases the CGM cost for capillary glucose test strips.
- Has accuracy concerns
Please see flow charts for guidance on treatment choices.